3rd Quarter - Report

MCLARTY INBOUND LLC for VERTEX PHARMACEUTICALS INCORPORATED

Period 3rd Quarter 2026 Filed Oct 20, 2026 Signed by Claire P. Kaiser, Senior Managing Director

Official filing
Firm
MCLARTY INBOUND LLC
Client
VERTEX PHARMACEUTICALS INCORPORATED
Income
$90,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

International trade issues impacting pharmaceutical industry.

LobbyistCovered position, as disclosed
KATE KALUTKIEWICZ —

Contacted: U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.